Myasthenia gravis (gMB)

Myasthenia gravis (gMB) is a rare chronic condition that causes weakness if voluntary muscles including muscles in the face, throat and muscles connecting to a person’s bones. It is an autoimmune disease meaning the body’s defence system attacks healthy cells or proteins mistakenly.

4MCS are running a clinical trial to test a new medication versus a non-active substance (placebo) to see if it can improve symptoms of myasthenia gravis.

Eligibility Criteria

  • Male or female between ages 18-75 years old
  • Diagnosis of Myasthenia gravis
  • On a stable standard of care gMB treatment
  • Other criteria with apply based on medical history

To enrol on a myasthenia gravis clinical trial or learn more about participating, please fill in the form below and we will be in touch. Alternatively, please call our team on 03300 575 838.

Register interest:

You have the right to withdraw your consent to the processing of your information at any time by sending an email to [email protected]. Your withdrawal of consent does not affect the lawfulness of the processing before the withdrawal.